Walleye Trading
MRNA icon

Walleye Trading’s Moderna MRNA Stock Holding History

Walleye Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.7M Sell
407,500
-38,000
-9% -$1.77M 0.03% 499
2025
Q4 		$13.1M Sell
445,500
-31,700
-7% -$861K 0.02% 796
2025
Q3 		$12.3M Buy
477,200
+120,600
+34% +$3.36M 0.02% 796
2025
Q2 		$9.84M Buy
356,600
+28,100
+9% +$740K 0.02% 826
2025
Q1 		$9.31M Buy
328,500
+125,500
+62% +$4.45M 0.02% 765
2024
Q4 		$8.44M Buy
203,000
+14,000
+7% +$669K 0.02% 878
2024
Q3 		$12.6M Buy
189,000
+111,000
+142% +$10.2M 0.03% 656
2024
Q2 		$9.26M Buy
78,000
+20,500
+36% +$2.59M 0.02% 720
2024
Q1 		$6.13M Sell
57,500
-189,600
-77% -$19.1M 0.01% 1004
2023
Q4 		$24.6M Buy
247,100
+59,700
+32% +$5.02M 0.05% 366
2023
Q3 		$19.4M Sell
187,400
-9,700
-5% -$1.08M 0.05% 381
2023
Q2 		$23.9M Sell
197,100
-125,600
-39% -$16.8M 0.07% 245
2023
Q1 		$49.6M Buy
322,700
+15,300
+5% +$2.52M 0.11% 142
2022
Q4 		$55.2M Sell
307,400
-1,800
-0.6% -$294K 0.16% 114
2022
Q3 		$36.6M Buy
309,200
+122,300
+65% +$18.6M 0.11% 159
2022
Q2 		$26.7M Buy
186,900
+33,300
+22% +$4.76M 0.09% 234
2022
Q1 		$26.5M Buy
153,600
+125,700
+451% +$21.2M 0.08% 262
2021
Q4 		$7.09M Buy
27,900
+8,000
+40% +$2.34M 0.02% 784
2021
Q3 		$7.66M Sell
19,900
-61,000
-75% -$22.5M 0.03% 684
2021
Q2 		$19M Buy
80,900
+8,300
+11% +$1.48M 0.07% 241
2021
Q1 		$9.51M Buy
72,600
+55,700
+330% +$8.07M 0.04% 347
2020
Q4 		$1.77M Sell
16,900
-13,700
-45% -$1.39M 0.01% 1480
2020
Q3 		$2.17M Buy
30,600
+17,200
+128% +$1.2M 0.01% 1069
2020
Q2 		$860K Buy
13,400
+3,700
+38% +$203K 0.01% 1794
2020
Q1 		$291K Sell
9,700
-22,900
-70% -$527K ﹤0.01% 2321
2019
Q4 		$638K Sell
32,600
-37,100
-53% -$658K ﹤0.01% 2204
2019
Q3 		$1.11M Sell
69,700
-70,300
-50% -$1.04M 0.01% 1518
2019
Q2 		$2.05M Buy
+140,000
New +$3.01M 0.02% 1026

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Trading's MRNA Position: Q1 2026 in Review

Walleye Trading reduced its Moderna (MRNA) stake by 98% in Q1 2026, selling an estimated $14.8M and leaving 7,257 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2764.

Walleye Trading first reported a position in MRNA in Q2 2019 and has held it in 20 quarters since. The position peaked at $25M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Walleye Trading held 7,257 shares of Moderna worth $369K as of Q1 2026.
  • Walleye Trading sold 316,376 Moderna shares in Q1 2026, an estimated $14.8M.
  • Moderna made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2764 holding.
  • Walleye Trading first reported a position in Moderna in Q2 2019 and has held it in 20 quarters since.
  • Walleye Trading's Moderna position peaked at $25M in Q3 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.